SGLT2 inhibitors in the real world: too good to be true?

被引：8
|
作者：
Fitchett, David [1 ,2 ]
机构：
[1] St Michaels Hosp, Div Cardiol, Toronto, ON M5B 1W8, Canada
[2] Univ Toronto, Dept Med, Toronto, ON, Canada
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2017年 / 5卷 / 09期
关键词：
CARDIOVASCULAR OUTCOMES;
D O I：
10.1016/S2213-8587(17)30259-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：673 / 675
页数：4
相关论文
共 50 条
  • [21] Ketoacidosis with SGLT2 Inhibitors
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1471): : 94 - 94
  • [22] SGLT2 inhibitors and cardioprotection
    Chen, S.
    Wang, Q.
    Christodoulou, A.
    Mylonos, N.
    Bakker, D.
    Wakker, V.
    Hollmann, M. W.
    Weber, N. C.
    Coronel, R.
    Christoffels, V.
    Andreadou, I.
    Zuurbier, C. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
  • [23] SGLT2 inhibitors: are they safe?
    Filippas-Ntekouan, Sebastian
    Filippatos, Theodosios D.
    Elisaf, Moses S.
    POSTGRADUATE MEDICINE, 2018, 130 (01) : 72 - 82
  • [24] REAL WORLD OUTCOMES OF SGLT2 INHIBITION IN A HFREF POPULATION
    Savage, Patrick
    McElhatton, Daniel
    Campbell, Michael
    Bamford, Jordan
    Reid, Rebecca
    Dixon, Lana
    HEART, 2022, 108 : A92 - A93
  • [25] Cardiovascular and renal outcomes with SGLT2 inhibitors: Real-life observational studies in older patients with type 2 diabetes SGLT2 inhibitors in elderly and real life
    Scheen, Andre J.
    DIABETES EPIDEMIOLOGY AND MANAGEMENT, 2023, 10
  • [26] Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population
    Kotinas, Alexios S.
    Gitto, Mauro
    Terzi, Riccardo
    Oliva, Angelo
    Zagoreo, Jorgele
    Reimers, Bernhard
    Stefanini, Giulio G.
    Mirani, Marco
    Favacchio, Giuseppe
    Condorelli, Gianluigi
    Panico, Cristina
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G) : G113 - +
  • [27] Relative and Absolute Risks of Adverse Events with Real-World Use of SGLT2 Inhibitors in CKD
    Odutayo, Ayodele
    Levin, Adeera
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (05): : 557 - 559
  • [28] Effects of SGLT2 inhibitors on left and right ventricular function in a real-world diabetic population
    Kotinas, Alexios S.
    Gitto, Mauro
    Terzi, Riccardo
    Oliva, Angelo
    Zagoreo, Jorgele
    Reimers, Bernhard
    Stefanini, Giulio G.
    Mirani, Marco
    Favacchio, Giuseppe
    Condorelli, Gianluigi
    Panico, Cristina
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [29] DIABETIC COMPLICATIONS ASSOCIATED WITH SGLT2 AND DPP4 INHIBITORS: A REAL-WORLD APPROACH
    Kashambwa, R.
    Stapff, M.
    VALUE IN HEALTH, 2019, 22 : S141 - S141
  • [30] Development of SGLT1 and SGLT2 inhibitors
    Timo Rieg
    Volker Vallon
    Diabetologia, 2018, 61 : 2079 - 2086
12345